InvestorsObserver
×
News Home

What is the Market's View on Acurx Pharmaceuticals Inc (ACXP) Stock's Price and Volume Trends Tuesday?

Tuesday, April 25, 2023 11:05 AM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Acurx Pharmaceuticals Inc (ACXP) Stock's Price and Volume Trends Tuesday?

Overall market sentiment has been high on Acurx Pharmaceuticals Inc (ACXP) stock lately. ACXP receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Acurx Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ACXP!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ACXP Stock Today?

Acurx Pharmaceuticals Inc (ACXP) stock is flat 0% while the S&P 500 has fallen -0.69% as of 10:46 AM on Tuesday, Apr 25. ACXP is flat $0.00 from the previous closing price of $3.23 on volume of 26,943 shares. Over the past year the S&P 500 is down -4.37% while ACXP has fallen -19.25%. ACXP lost -$1.12 per share in the over the last 12 months.

More About Acurx Pharmaceuticals Inc

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. Click Here to get the full Stock Report for Acurx Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App